I am a Stanford-trained neuroscientist with over a decade of experience developing and translating neuromodulation technologies from early concept through to FDA clearance and commercialization. My work spans both non-invasive and invasive approaches, and I have led and supported multiple FDA submissions, designed and executed clinical trials across academic, research, and industry settings, and contributed to the development of novel treatment approaches now used in clinical practice. I have presented this work at numerous national and international conferences, and bring a deep understanding of what it takes to translate a promising idea into an FDA-cleared and commercially viable treatment.

What distinguishes my approach is a comprehensive, end-to-end perspective, combining scientific rigor, clinical insight, and regulatory strategy. I understand not only how to generate clinical evidence, but how the data is interpreted by regulators, clinicians, and investors, and where breakdowns most commonly occur. This allows me to help organizations de-risk development, strengthen their evidence base, and accelerate the path to real-world impact.

How I Work

Advising Investors

I support investors in evaluating neurotechnology and mental health ventures with a level of scientific and clinical depth that is often difficult to access during diligence. My experience developing neuromodulation therapies and preparing FDA submissions enables me to evaluate whether the underlying scientific principles of the product are robust, the quality of the clinical evidence, and whether the proposed regulatory pathway is realistic.

I focus on identifying key risks early; whether in mechanism, trial design, endpoint selection, or regulatory strategy, and distinguishing between technologies that are scientifically compelling versus those that are commercially viable. This helps investors make informed decisions with a clear understanding of both upside potential and execution risk.

Research Clinics & Clinical Organizations

I work with clinics and clinical organizations to design, optimize, and scale research programs that generate high-quality, actionable data. Having run clinical trials across academic centers, private clinics, and industry, I understand both the scientific and operational challenges of conducting research in real-world settings.

I assist in designing clinical trials, optimizing data collection processes, and creating research infrastructure in clinical settings. My focus is on ensuring that clinical data is not only collected efficiently, but structured in a way that can support publication, regulatory use, and future growth.

Academic & Research Partnerships

I collaborate with academic groups and research teams to strengthen clinical trial design, data analysis, and scientific communication. My background in both academia and industry allows me to bridge the gap between rigorous scientific inquiry and translational impact.

I support manuscript development, grant strategy, and advanced data analysis, with a focus on producing work that is both methodologically robust and clinically meaningful. I also bring a practical understanding of how research can be positioned to inform regulatory strategy and future commercialization pathways.